OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00302259

Levima Advanced Materials Corp

Diversified ChemicalsVerified

Levima's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.82, indicating a significant reliance on debt financing. The company's liquidity position is medium, as reflected in its current ratio of 0.53, which is below 1 and suggests potential short-term liquidity constraints. Free cash flow is negative at -3.58 billion CNY, driven by a capital expenditure of -4.27 billion CNY, indicating that the company is investing heavily in its operations. Profitability metrics show that Levima's return on equity (ROE) is 4.11%, and its return on assets (ROA) is 1.24%, both of which are below the typical thresholds for strong performance in the Diversified Chemicals industry. The company's net income of 305.71 million CNY is modest relative to its total assets of 24.57 billion CNY, suggesting that it is not generating strong returns on its asset base. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification could expose the company to higher operational and market risks, particularly in the event of regional economic downturns or supply chain disruptions. Looking ahead, Levima's growth trajectory appears to be constrained. The company's free cash flow is negative, and its capital expenditures are substantial, which may limit its ability to reinvest in growth opportunities or return value to shareholders. Analysts have provided a mean price target of 31.25 CNY, with a median and high target also at 31.25 CNY, indicating a relatively narrow range of expectations for the stock. The company faces several risk factors, including its high debt load and negative free cash flow, which could lead to liquidity pressures. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate signs of equity dilution. However, the company's capital structure and cash flow dynamics suggest that it may need to raise additional capital in the future, which could result in dilution for existing shareholders. Recent events, including the company's latest financial filings, show a consistent pattern of high capital expenditures and negative free cash flow. The company has not disclosed any material changes in its business strategy or operations in the most recent filings, and there are no notable transcripts from investor calls or earnings reports that suggest a shift in direction.

30-day price · 003022+3.44 (+16.6%)
Low$19.45High$27.49Close$24.20As of22 May, 00:00 UTC
Profile
CompanyLevima Advanced Materials Corp
Ticker003022.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Levima Advanced Materials Corp is a diversified chemicals company that produces and sells a range of chemical products, primarily generating revenue through the sale of these products to industrial and manufacturing customers.

Classification. Levima is classified under the Basic Materials economic sector, within the Chemicals business sector, and the Diversified Chemicals industry, with a high confidence level of 0.92 based on verified market data.

Levima's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.82, indicating a significant reliance on debt financing. The company's liquidity position is medium, as reflected in its current ratio of 0.53, which is below 1 and suggests potential short-term liquidity constraints. Free cash flow is negative at -3.58 billion CNY, driven by a capital expenditure of -4.27 billion CNY, indicating that the company is investing heavily in its operations. Profitability metrics show that Levima's return on equity (ROE) is 4.11%, and its return on assets (ROA) is 1.24%, both of which are below the typical thresholds for strong performance in the Diversified Chemicals industry. The company's net income of 305.71 million CNY is modest relative to its total assets of 24.57 billion CNY, suggesting that it is not generating strong returns on its asset base. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification could expose the company to higher operational and market risks, particularly in the event of regional economic downturns or supply chain disruptions. Looking ahead, Levima's growth trajectory appears to be constrained. The company's free cash flow is negative, and its capital expenditures are substantial, which may limit its ability to reinvest in growth opportunities or return value to shareholders. Analysts have provided a mean price target of 31.25 CNY, with a median and high target also at 31.25 CNY, indicating a relatively narrow range of expectations for the stock. The company faces several risk factors, including its high debt load and negative free cash flow, which could lead to liquidity pressures. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate signs of equity dilution. However, the company's capital structure and cash flow dynamics suggest that it may need to raise additional capital in the future, which could result in dilution for existing shareholders. Recent events, including the company's latest financial filings, show a consistent pattern of high capital expenditures and negative free cash flow. The company has not disclosed any material changes in its business strategy or operations in the most recent filings, and there are no notable transcripts from investor calls or earnings reports that suggest a shift in direction.
Key takeaways
  • Levima has a high debt-to-equity ratio of 1.82, indicating a significant reliance on debt financing.
  • The company's return on equity (4.11%) and return on assets (1.24%) are below typical industry benchmarks.
  • Levima's free cash flow is negative at -3.58 billion CNY, driven by a large capital expenditure of -4.27 billion CNY.
  • The company's revenue is concentrated in a single business segment, with no material geographic diversification.
  • Analysts have provided a mean price target of 31.25 CNY, with a median and high target also at 31.25 CNY.
  • The company faces liquidity risks due to its current ratio of 0.53 and negative free cash flow.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$6.34B
Gross profit$1.17B
Operating income$345.6M
Net income$305.7M
R&D
SG&A
D&A
SBC
Operating cash flow$587.0M
CapEx-$4.27B
Free cash flow-$3.58B
Total assets$24.57B
Total liabilities$17.13B
Total equity$7.44B
Cash & equivalents
Long-term debt$13.56B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$6.34B$345.6M$305.7M-$3.58B
FY-1$6.27B$315.4M$234.4M-$2.79B
FY-2$6.78B$519.1M$446.1M-$2.47B
FY-3$8.16B$852.9M$866.2M-$723.2M
FY-4$7.58B$1.27B$1.09B$506.2M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$24.57B$7.44B
FY-1$19.52B$7.24B
FY-2$17.02B$7.12B
FY-3$14.05B$6.94B
FY-4$12.09B$6.34B
PeriodOCFCapExFCFSBC
FY0$587.0M-$4.27B-$3.58B
FY-1$593.7M-$3.36B-$2.79B
FY-2$875.4M-$3.12B-$2.47B
FY-3$1.32B-$1.78B-$723.2M
FY-4$1.27B-$442.4M$506.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$2.25B$206.1M$144.7M
FQ-1$1.77B$69.1M$73.3M
FQ-2$1.66B$83.3M$71.7M
FQ-3$1.37B$101.3M$89.3M
FQ-4$1.54B$92.6M$71.4M
FQ-5$1.30B$99.1M$56.1M
FQ-6$1.65B$33.5M$37.6M
FQ-7$1.83B$117.0M$89.3M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$26.17B$7.59B$2.41B
FQ-1$24.57B$7.44B
FQ-2$22.78B$7.38B$2.64B
FQ-3$22.10B$7.31B
FQ-4$21.35B$7.31B$3.36B
FQ-5$19.52B$7.24B
FQ-6$18.70B$7.19B$2.40B
FQ-7$18.44B$7.16B
PeriodOCFCapExFCFSBC
FQ0$221.7M-$1.02B
FQ-1$587.0M-$4.27B
FQ-2$261.3M-$2.89B
FQ-3$259.9M-$1.83B
FQ-4$31.3M-$777.2M
FQ-5$593.7M-$3.36B
FQ-6$415.5M-$2.32B
FQ-7$248.8M-$1.62B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$7.44B
Net cash-$13.56B
Current ratio0.5
Debt/Equity1.8
ROA1.2%
ROE4.1%
Cash conversion1.9%
CapEx/Revenue-67.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 80 companies
Metric003022Activity
Op margin5.5%-1.1% medp25 -1.1% · p75 -1.1%top quartile
Net margin4.8%-6.6% medp25 -6.6% · p75 -6.6%top quartile
Gross margin18.5%12.9% medp25 12.9% · p75 12.9%top quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-67.3%-7.1% medp25 -12.7% · p75 -4.4%bottom quartile
Debt / equity182.0%1639.6% medp25 1639.6% · p75 1639.6%bottom quartile
Observations
IR observations
Mean price target31.25 CNY
Median price target31.25 CNY
High price target31.25 CNY
Low price target31.25 CNY
Mean recommendation1.67 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.45 CNY
Last actual EPS0.23 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 01:01 UTCJob: a33790c8